Lexeo Therapeutics · 1 month ago
Sr. Manager, Corporate Strategy and New Product Planning
Lexeo Therapeutics is a clinical-stage genetic medicine company pioneering cardiac genetic medicine candidates to treat inherited cardiovascular diseases. The Senior Manager, Corporate Strategy and New Product Planning will shape the commercial direction of leading cardiac programs, focusing on market research, corporate strategy, and collaboration across departments.
BiotechnologyLife ScienceTherapeutics
Responsibilities
Conduct market research, including primary and secondary research, to outline market dynamics in FA, ACM and across other genetic medicine targets, such as unmet needs, key stakeholders, existing treatment paradigms, and competition, focusing on the U.S. and key international markets
Leverage research and insights to define how the company’s gene therapy candidates may meet unmet needs and impact future treatment paradigms
Collaborate closely with clinical colleagues to understand target product profiles and identify patient populations eligible for treatment
Identify and map key stakeholders involved in the treatment of FA and ACM, as well as those involved in the potential administration of cardiac gene therapy
Compile information on current treatment costs, payer perspectives, patient coverage types, treatment expenditure, and other medical costs
Analyze commercially available gene therapies in key markets, identifying successful constructs that maximize patient access or enable value-based reimbursement
Outline recommended investments and timelines for commercial scale-up over the next three years, including necessary commercial capabilities and colleagues
Develop and implement operational plans to ensure the efficient execution of commercial and corporate strategies
Support senior executives and business development colleagues with corporate strategy initiatives such as pipeline prioritization and development strategy optimization and other organizational planning
Monitor and evaluate the performance of commercial initiatives, providing insights and recommendations for continuous improvement
Advance Lexeo objectives commercially, including support for corporate communications, media awareness, and internal employee initiatives that increase knowledge and understanding of lead programs and strategies
Work closely with colleagues in Clinical Development, Medical Affairs, Program Management, and other relevant departments to ensure cohesive strategy execution
Report to the Senior Director of Commercial Marketing, regularly updating on project progress and strategic recommendations
Present findings and strategic recommendations to company leadership, facilitating informed decision-making
Qualification
Required
MBA with 7-10 years of professional experience in consulting, finance, marketing, sales, or biopharmaceuticals, with a focus on commercial strategy and operations
Experience in the healthcare and biopharmaceutical industry, with a deep understanding of global biopharmaceutical market trends
Proven ability to synthesize data from multiple sources and distill insights into clear, actionable business strategies
Strong project management skills with meticulous attention to detail and the ability to manage multiple priorities in a fast-paced environment
Excellent interpersonal communication skills and a track record of successful cross-functional collaboration
Ability to operate independently, driving projects to completion with minimal oversight
Company
Lexeo Therapeutics
LEXEO Therapeutics utilizes gene therapy to treat genetically defined cardiovascular and central nervous system diseases.
Funding
Current Stage
Public CompanyTotal Funding
$514MKey Investors
Balyasny Asset ManagementSarepta Therapeutics
2025-10-16Post Ipo Equity· $154M
2025-05-27Post Ipo Equity· $80M
2024-03-11Post Ipo Equity· $95M
Recent News
2026-01-09
Company data provided by crunchbase